Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.

Published in: CNS drugs (2023)

Pediatric and adult ADHD patients who have experienced less than optimal response to atomoxetine demonstrate rapid improvement in inattention and in hyperactivity/impulsivity with greater tolerability on extended-release viloxazine.

Keyphrases

attention deficit hyperactivity disorder
autism spectrum disorder
working memory
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
clinical trial
quantum dots
study protocol
loop mediated isothermal amplification